Geopolitics Alpha

Smith+Nephew cuts guidance on weak orthopaedics demand

Published . Updated .

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

Smith+Nephew cuts guidance on weak orthopaedics demand

Investing.com -- Smith+Nephew on Wednesday reported third quarter revenue of $1.55 billion, up 3.4% both on an underlying and reported basis from the same period last year. The medical device company revised its full-year revenue growth guidance to around 3%, down from a

Directly affected

  • SNN Smith & Nephew+0.4% 6d

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that Smith & Nephew belongs to, so it often moves with news about it.

  • STE Steris+6.2% 16d

    Steris is a peer of Smith & Nephew in orthopedic, prosthetic and surgical appliances and supplies; rivals often move on the same news.

  • ISRG Intuitive Surgical+10.6% 30d

    Intuitive Surgical is a peer of Smith & Nephew in orthopedic, prosthetic and surgical appliances and supplies; rivals often move on the same news.

  • EW Edwards Lifesciences+9.7% 30d

    Edwards Lifesciences is a peer of Smith & Nephew in orthopedic, prosthetic and surgical appliances and supplies; rivals often move on the same news.

  • ZBH Zimmer Biomet Holdings

    Zimmer Biomet Holdings is a peer of Smith & Nephew in orthopedic, prosthetic and surgical appliances and supplies; rivals often move on the same news.

  • ALGN Align Technology+0.7% 19d

    Align Technology is a peer of Smith & Nephew in orthopedic, prosthetic and surgical appliances and supplies; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
SNN-0.17%-1.56%baseafter closeafter closeafter closeafter close
XLV-2.31%+0.48%baseafter closeafter closeafter closeafter close
STE-1.06%-1.73%baseafter closeafter closeafter closeafter close
ISRG+0.78%-1.96%baseafter closeafter closeafter closeafter close
EW-3.60%-3.37%baseafter closeafter closeafter closeafter close
ZBH-0.65%-2.65%baseafter closeafter closeafter closeafter close
ALGN+1.14%-1.07%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Smith+Nephew cuts guidance on weak orthopaedics demand Yahoo Finance Singapore

Source: Yahoo Finance

This story

CompanyWhenMoveStatus
ALGNthree days earlier-1.07%final price
ALGNfive days earlier+1.14%final price
EWthree days earlier-3.37%final price
EWfive days earlier-3.60%final price
ISRGthree days earlier-1.96%final price
ISRGfive days earlier+0.78%final price
SNNthree days earlier-1.56%final price
SNNfive days earlier-0.17%final price
STEthree days earlier-1.73%final price
STEfive days earlier-1.06%final price
XLVthree days earlier+0.48%final price
XLVfive days earlier-2.31%final price
ZBHthree days earlier-2.65%final price
ZBHfive days earlier-0.65%final price

Trades by members of Congress and officials in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

How solid “Smith+Nephew cuts guidance on weak orthopaedics demand” looks

12 out of 100

“Smith+Nephew cuts guidance on weak orthopaedics demand” scores 12 out of 100. The score uses 1 sources.